The European Commission’s plan to introduce a transferable exclusivity voucher scheme in the EU to encourage the development of new antimicrobial drugs has run into trouble after a majority of the EU member states came out against the idea.
In a letter entitled “Novel stimuli for the development and keeping on the market of antimicrobials,” the Dutch government and 13 other member states say that while they recognize that new incentives are needed to address market failure and lack of availability of
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?